Obesity: a chronic relapsing progressive disease process. A position statement of the World Obesity Federation

Obesity Reviews

Volumn 18, Issue 7, 2017, Pages 715-723

  Bray, G A ^a   Kim, K K ^b   Wilding, J P H ^c,d  

^a PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^b Seoul National University   (South Korea)

^c UNIVERSITY OF LIVERPOOL   (United Kingdom)

^d UNIVERSITY HOSPITAL AINTREE   (United Kingdom)

Author keywords

Causes of obesity; epidemiology of obesity; pathophysiology; risks of obesity

Indexed keywords

ADIPOCYTE; ARTICLE; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; CHOLELITHIASIS; CHRONIC DISEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; EPIGENETICS; HEREDITY; HUMAN; HYPERTENSION; MALIGNANT NEOPLASM; NONHUMAN; OBESITY; OSTEOARTHRITIS; RECURRENT DISEASE; SLEEP DISORDERED BREATHING; BODY WEIGHT GAIN; CARBOHYDRATE DIET; COMPLICATION; DIET; ENVIRONMENT; EXERCISE; FAT INTAKE; FOOD; PATHOPHYSIOLOGY;

CHRONIC DISEASE; DIET; DIETARY CARBOHYDRATES; DIETARY FATS; ENVIRONMENT; EXERCISE; FOOD; HUMANS; OBESITY; RECURRENCE; WEIGHT GAIN;

EID: 85019131529     PISSN: 14677881     EISSN: 1467789X     Source Type: Journal    
DOI: 10.1111/obr.12551     Document Type: Article

References (93)

1. National Institutes of Health Consensus Development Panel on the Health Implications of Obesity, Health implications of obesity: National Institutes of Health Consensus Development Conference Statement. Ann Intern Med. 1985; 103(6 Part 2): 1073–1077.
2. Downey MB. Obesity is a disease entity. Am Heart J 2001; 142: 1091–1094.
3. Bray GA. Obesity is a chronic, relapsing neurochemical disease. Intern J Obes 2004; 28: 34–38.
4. Allison DB, Downey M, Atkinson RL et al. Obesity as a disease: a white paper on evidence and arguments commissioned by the Council of the Obesity Society. Obesity (Silver Spring) 2008; 16: 1161–1177.
5. Kyle TK, Dhurandhar EJ, Allison DB. Regarding obesity as a disease. Endocrinol Metab Clin N Am 2016; 45: 511–520.
6. Church TS. Why obesity should be treated as a disease. Curr Sports Med Rep 2014; 13: 205–206.
7. Faber K. Nosography in Modern Internal Medicine. Paul B. Hoeber, Inc.: New York, 1923.
8. JASSO. Examination committee of criteria for ‘obesity disease’ in Japan; Japan Society for the Study of Obesity. New criteria for ‘obesity disease’ in Japan. Circ J 2002; 66: 987–992.
9. Scottish Intercollegiate Guidelines Network (SIGN). Clinical management of obesity: a national clinical guideline No 15 February 2010
10. American Society for Metabolic and Bariatric Surgery. . Accessed September 11, 2013.
11. Garvey WT, Garber AJ, Mechanick JI et al., for the AACE Obesity Scientific Committee. American Association of Clinical Endocrinologists and American College of Endocrinology consensus conference on obesity: building an evidence base for comprehensive action. Endocr Pract 2014; 20: 956–976.
12. Garvey WT, Mechanick JI, Brett EM et al. Reviewers of the AACE/ACE Obesity Clinical Practice Guidelines American Association of Clinical Endocrinologists and American College of Endocrinology Comprehensive Clinical Practice Guidelines for Medical Care of Patients with Obesity. Endocr Pract 2016; 22(Suppl 3): 1–203.
13. Nagoya Declaration 2015. The 8th Asia-Oceania Conference on Obesity (AOCO 2015). http://www.jasso.or.jp/data/data/pdf/nagoya2015.pdf
14. Venditti EM, Bray GA, Carrion-Peterson ML et al., for the Diabetes Prevention Research Group. First versus repeat treatment with a lifestyle intervention program: attendance and weight loss outcomes. Intern J Obes 2008; 32: 1537–1664.
15. Sjöström L, Narbro K, Sjöström CD et al. for the Swedish Obese Subjects Study. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med 2007; 357: 741–752.
16. Wing RR, Bolin P, Brancati FL et al., for the Look AHEAD Research Group. Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. New Engl J Med 2013; 369: 145–154.
17. Hall KD, Guo J. Obesity energetics: body weight regulation and the effects of diet composition. Gastroenterology 2017; 152(7): 1718–1727.
18. Folsom AR, Jensen MD, Jacobs DR, Hilner JE, Tsai AW, Schreiner PJ. Serum leptin and weight gain over 8 years in African American and Caucasian young adults. Obes Res 1999; 7: 1–8.
19. Sumithran P, Prendergast LA, Delbridge E et al. Long-term persistence of hormonal adaptations to weight loss. N Engl J Med. 2011; 365: 1597–1604.
20. Sievenpiper JL, Jenkins DJ, Josse RG, Leiter LA, Vuksan V. Simple skinfold-thickness measurements complement conventional anthropometric assessments in predicting glucose tolerance. Am J Clin Nutr 2001; 73: 567–573.
21. Jensen MD, Ryan DH, Donato KA et al. Guidelines (2013) for managing overweight and obesity in adults. Obesity 2014; 22(S2) S1-S-410.
22. Cerhan JR, Moore SC, Jacobs EJ et al. A pooled analysis of waist circumference and mortality in 650,000 adults. Mayo Clin Proc 2014; 89: 335–345.
23. Bray GA, DeLany JP, Harsha DW, Volaufova J, Champagne CM. Evaluation of body fat in fatter and leaner 10-y old African-American and white children: the Baton Rouge Children's Study. Am J Clin Nutr 2001; 73: 687–702.
24. Al-Gindan YY, Hankey CR, Govan L, Gallagher D, Heymsfield SB, Lean ME. Derivation and validation of simple anthropometric equations to predict adipose tissue mass and total fat mass with MRI as the reference method. Br J Nutr 2015; 114: 1852–1867.
25. Bray GA, Jablonski KA, Fujimopto WY et al., for the Diabetes Prevention Program Research Group. Relation of central adiposity and body mass index to the development of diabetes in the diabetes prevention program. Am J Clin Nutr 2008; 87: 1212–1218.
26. Whitlock G, Lewington S, Sherliker P et al. Body-mass index and cause-specific mortality I 900,000 adults: collaborative analyses of 57 prospective studies. Lancet 2009; 373: 1083–1096.
27. Berrington de Gonzalez A, Hartge P, Cerhan JR et al. Body-mass index and mortality among 1.46 million white adults. N Engl J Med 2010; 363: 2211–2219.
28. Boggs DA, Rosenberg L, Cozier YC et al. General and abdominal obesity and risk of death among black women. N Engl J Med 2011; 365: 901–908.
29. Bray GA. A guide to obesity and the metabolic syndrome: origins and treatment. New York: CRC Press: Taylor and Francis Group. 2011.
30. Bray GA, Fruhbeck G, Ryan DH, Wilding JPH. Management of Obesity. Lancet 2016; 388: 759–760.
31. Sjostrom CD, Lissner L, Sjostrom L. Relationships between changes in body composition and changes in cardiovascular risk factors: the Swedish obese subjects intervention study. Obes Res 1997; 5: 519–530.
32. Cawley J, Meyerhoefer C. The medical care costs of obesity: an instrumental variables approach. J Health Econ 2012; 31: 219–230.
33. Loeppke R, Taitel M, Haufle V, Parry T, Kessler RC, Jinnett K. Health and productivity as a business strategy: a multiemployer study. J Occup Environ Med 2009; 51: 411–428.
34. Tsai AG, Williamson DF, Glick HA. Direct medical cost of overweight and obesity in the USA: a quantative systematic review. Obes Rev 2011; 12: 50–61.
35. Finkelstein EA, Khavjou OA, Thompson H et al. Obesity and severe obesity forecasts through 2030. Am J Prev Med 2012; 42: 563–570.
36. Finkelstein EA, Graham WC, Malhotra R. Lifetime direct medical costs of childhood obesity. Pediatrics 2014; 133: 854–862.
37. Wang YC, McPherson K, Marsh T, Gortmaker SL, Brown M. Health and economic burden of the projected obesity trends in the USA and the UK. Lancet 2011; 378: 815–825.
38. Garrow JS. Treat Obesity Seriously: A Clinical Manual. Churchill Livingstone: New York, 1981.
39. Flemyng M. A Discourse on the Nature, Causes and Cure of Corpulency. L. David and C. Reymers: London, 1760.Illustrated by a remarkable case, read before the Royal Society, November 1757 and now first published
40. Wadd W. Cursory Remarks on Corpulence; or Obesity Considered as a Disease: With a Critical Examination of Ancient and Modern Opinion, Relative to its Causes and Cure. J. Callow: London, 1816.
41. Mechanick JI, Garber AJ, Handelsman Y, Garvey WT. American Association of Clinical Endocrinologists' position statement on obesity and obesity medicine. Endocr Pract 2012; 18: 642–648.
42. Wildman RP, Muntner P, Reynolds K et al. The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999–2004). Arch Int Med 2008; 168: 1617–1624.
43. Kramer CK, Zinman B, Retnakaran R. Are metabolically healthy overweight and obesity benign conditions?: a systematic review and meta-analysis. Ann Intern Med 2013; 159: 758–769.
44. Batsis JA, Sahakyan KR, Rodriguez-Escudero JP, Bartels SJ, Lopez-Jimenez F. Normal weight obesity and functional outcomes in older adults. Eur J Intern Med 2014; 25: 517–522.
45. Sahakyan KR, Somers VK, Rodriguez-Escudero JP et al. Normal-weight central obesity: implications for total and cardiovascular mortality. Ann Intern Med 2015; 163: 827–835.
46. Hubert HB, Feinleib M, McNamara PM, Castelli WP. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham heart study. Circulation 1983; 67: 968–977.
47. Lajous M, Banack HR, Kaufman JS, Hernán MA. Should patients with chronic disease be told to gain weight? The obesity paradox and selection bias. Am J Med 2015; 128: 334–336.
48. Nordsiek FW. An epidemiological approach to obesity. Am J Public Health. 1964; 54: 1689–1698.
49. Bray GA. Obesity: the disease. J Med Chem 2006; 49: 4001–4007.
50. Putnam JJ, Allshouse JE. Food consumption, prices, and expenditures, 1970–1997. USDA Food and Agriculture Economic Division. Economic Research Service Bull 1999; 965: 1–155.
51. Scully T. New insights for obesity biology. Nature 2015; 518: 197–206.
52. Moss M. Salt, Sugar Fat: How the Food Giants Hooked Us. Random House: New York, 2013, p. 132.
53. Bray GA, Wadden TA. Improving long-term weight loss maintenance: can we do it? Obesity 2015; 23: 2–3.
54. Pandit R, Mercer JG, Overduin J, la Fleur SE, Adan RAH. Dietary factors affect food reward and motivation to eat. Obes Facts 2012; 5: 221–242.
55. de Macedo IC, de Freitas JS, da Silva Torres IL. The influence of palatable diets in reward system activation: a mini review. Adv Pharmacol Sci 2016; 2016 7238679.
56. Bray GA. Is sugar addictive? Diabetes 2016; 65: 1797–1799.
57. Church TS, Thomas DM, Tudor-Locke C et al. Trends over 5 decades in U.S. occupation-related physical activity and their associations with obesity. PLoS One 2011; 6: e19657.
58. Janesick AS, Shioda T, Blumberg B. Transgenerational inheritance of prenatal obesogen exposure. Mol Cell Endocrinol 2014; 398: 31–35.
59. Keith SW, Redden DT, Katzmarzyk PT et al. Putative contributors to the secular increase in obesity: exploring the roads less traveled. Int J Obes 2006; 30: 1585–1594.
60. Loos RJ. Genetic determinants of common obesity and their value in prediction. Best Pract Res Clin Endocrinol Metab 2012; 26: 211–226.
61. Farooqi IS, O'Rahilly S. Genetic factors in human obesity. Obes Rev 2007; 8(Suppl 1): 37–40.
62. Locke AE, Kahali B, Berndt SI et al. Genetic studies of body mass index yield new insights for obesity biology. Nature 2015; 518: 197–206.
63. Shungin D, Winkler TW, Croteau-Chonka DC et al. New genetic loci link adipose and insulin biology to body fat distribution. Nature 2015; 518: 187–196.
64. Halberg N, Wernstedt-Asterholm I, Scherer PE. The adipocyte as an endocrine cell. Endocrinol Metab Clin North Am 2008; 37: 753–768.
65. Bray GA. From farm to fat cell: why aren't we all fat? Metabolism 2015; 64: 349–353.
66. Rosenbaum M, Knight R, Leibel RL. The gut microbiota in human energy homeostasis and obesity. Trends Endocrinol Metab 2015 Sep; 26: 493–501.
67. Arita Y, Kihara S, Ouchi N et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. 1999. Biochem Biophys Res Commun 2012; 425: 560–564.
68. Wall H, Smith C, Hubbard R. Body mass index and obstructive sleep apnoea in the UK: a cross-sectional study of the over-50s. Prim Care Respir J 2012; 21: 371–376.
69. Li C, Ford ES, Zhao G, Croft JB, Balluz LS, Mokdad AH. Prevalence of self-reported clinically diagnosed sleep apnea according to obesity status in men and women: National Health and Nutrition Examination Survey, 2005–2006. Prev Med 2010; 51: 18–23.
70. Tuomilehto H, Seppä J, Uusitupa M. Obesity and obstructive sleep apnea – clinical significance of weight loss. Sleep Med Rev 2013; 17: 321–329.
71. Neeland IJ, Ayers CR, Rohatgi AK et al. Associations of visceral and abdominal subcutaneous adipose tissue with markers of cardiac and metabolic risk in obese adults. Obesity (Silver Spring) 2013; 21: E439–E447.
72. Bonfrate L, Wang DQ, Garruti G, Portincasa P. Obesity and the risk and prognosis of gallstone disease and pancreatitis. Best Pract Res Clin Gastroenterol 2014; 28: 623–635.
73. DeFronzo RA, Ferrannini E, Groop L et al. Type 2 diabetes mellitus. Nat Rev Dis Primers 2015; 1: 15019.
74. Hu G, Lindström J, Valle TT et al. Physical activity, body mass index, and risk of type 2 diabetes in patients with normal or impaired glucose regulation. Arch Intern Med 2004; 164: 892–896.
75. Padwal R, Leslie WD, Lix LM, Majumdar SR. Relationship among body fat percentage, body mass index, and all-cause mortality: a cohort study. Ann Intern Med 2016; 164: 532–541.
76. Menke A, Rust KF, Fradkin J, Cheng YJ, Cowie CC. Associations between trends in race/ethnicity, aging, and body mass index with diabetes prevalence in the United States: a series of cross-sectional studies increase in diabetes prevalence over time. Ann Int Med 2014; 161: 328–335.
77. Barker DJ, Eriksson JG, Forsén T, Osmond C. Fetal origins of adult disease: strength of effects and biological basis. Int J Epidemiol 2002; 31: 1235–1239.
78. Godfrey KM, Gluckman PD, Hanson MA. Developmental origins of metabolic disease: life course and intergenerational perspectives. Trends Endocrinol Metab 2010; 21: 199–205.
79. Kanaka-Gantenbein C. Fetal origins of adult diabetes. Ann N Y Acad Sci 2010; 1205: 99–105.
80. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 2003; 348: 1625–1638.
81. Hvidtfeldt UA, Gunter MJ, Lange T et al. Quantifying mediating effects of endogenous estrogen and insulin in the relation between obesity, alcohol consumption, and breast cancer. Cancer Epidemiol Biomarkers Prev 2012; 21: 1203–1212.
82. Yatsuya H, Folsom AR, Yamagishi K et al., for the Atherosclerosis Risk in Communities Study. Race- and sex-specific associations of obesity measures with ischemic stroke incidence in the atherosclerosis risk in communities (ARIC) study. Stroke 2010; 41: 417–425.
83. Schnabel RB, Yin X, Larson MG et al. Multiple inflammatory biomarkers in relation to cardiovascular events and mortality in the community. Arterioscler Thromb Vasc Biol 2013; 33: 1728–1733.
84. Foster GD, Sanders MH, Millman R et al., for the Sleep AHEAD Research Group. Obstructive sleep apnea among obese patients with type 2 diabetes. Diabetes Care 2009; 32: 1017–1019.
85. Bray GA. The obese patient. Major Problems in Internal Medicine 1976; 9: 1–450.
86. Radmard AR, Merat S, Kooraki S et al. Gallstone disease and obesity: a population-based study on abdominal fat distribution and gender differences. Ann Hepatol 2015; 14: 702–709.
87. Reyes C, Leyland KM, Peat G, Cooper C, Arden NK, Prieto-Alhambra D. Association between overweight and obesity and risk of clinically diagnosed knee, hip, and hand osteoarthritis: a population-based cohort study. Arthritis Rheumatol 2016; 68: 1869–1875.
88. Latner JD, Stunkard AJ. Getting worse: the stigmatization of obese children. Obes Res 2003; 11: 452–456.
89. Puhl RM, Brownell KD. Psychosocial origins of obesity stigma: toward changing a powerful and pervasive bias. Obes Rev 2003; 4: 213–227.
90. Lew EA, Garfinkel L. Mortality at ages 75 and older in the cancer prevention study (CPS I). CA Cancer J Clin 1990; 40: 210–224.
91. Stamler J, Wentworth D, Neaton JD. Is the relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the multiple risk factor intervention trial (MRFIT). JAMA 1986; 256: 2823–2828.
92. Stamler J, Neaton JD, Wentworth DN. Blood pressure (systolic and diastolic) and risk of fatal coronary heart disease. Hypertension 1989; 13(Suppl): I2–12.
93. Bray, GA. Coherent preventive and management strategies for obesity. In: The Origins and Consequences of Obesity. D.J. Chadwick and G. Cardew (ed). Ciba Foundation Symposium 201. London: John Wiley, 1996 pp 228–246.